Carolina Piterschi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Carolina Piterschi has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Lorina Vudu
Nicolae Testemitanu State University of Medicine and Pharmacy
4 shared publications - Stela Vudu
Nicolae Testemitanu State University of Medicine and Pharmacy
3 shared publications - Cristina Rizov2 shared publications
- Aristia Seremet1 shared publication
Catalina Meaun
Nicolae Testemitanu State University of Medicine and Pharmacy
1 shared publication- Diana Munteanu1 shared publication
Latest Publications
- 27 September 2025
- Published by Springer Nature
- p. 517-525
Ultrasound Assessment of Subcutaneous Adipose Tissue as a Predictor of Cardiometabolic Risk in Young Women
- 27 September 2025
- Published by Springer Nature
- p. 517-525
Ultrasound Assessment of Subcutaneous Adipose Tissue as a Predictor of Cardiometabolic Risk in Young Women
- 1 September 2025
- Published by Periodic Publication Moldovan Journal of Health Sciences in Moldovan Journal of Health Sciences
- Vol. 12 (3) , 86-91
Osteocalcin and metabolic dysfunction in young women with obesity
Introduction. Osteocalcin, a bone-derived hormone, has emerged as a potential regulator of energy metabolism, with roles in insulin sensitivity, glucose homeostasis, and lipid metabolism. Although an inverse association between osteocalcin and body mass index has been previously reported, data on its link with metabolic parameters in young, otherwise healthy women with obesity remain limited. The objective of this study was to investigate the relationship between circulating osteocalcin levels and key metabolic parameters in this specific population. Material and methods. A cross-sectional observational study was conducted among 85 Caucasian women aged 18-45 years, without chronic disease or medication use. Participants were classified into two groups: normal weight (BMI 18.524.9 kg/m², n = 47) and with obesity (BMI ≥ 30 kg/m², n = 38). Anthropometric, hemodynamic, and biochemical parameters, including glucose, insulin, lipid profile, osteocalcin, and adiponectin, were assessed. Insulin resistance was evaluated using HOMA-IR and QUICKI. Group comparisons and Pearson correlation analyses were performed. Results. Osteocalcin levels were significantly lower in the group of women with obesity compared to the normal weight group (12.99 ± 4.7 vs. 19.75 ± 4.09 ng/mL, p less than 0.001). It was inversely correlated with BMI (r = - 0.56), waist-to-hip ratio, waist-to-height ratio, insulin, HOMA-IR, total and LDL cholesterol, and positively associated with QUICKI (r = 0.39) and adiponectin (r = 0.31) (all p less than 0.001). A progressive decline in osteocalcin levels was observed across obesity grades. Conclusions. Circulating osteocalcin is inversely associated with adiposity and metabolic dysfunction, suggesting its potential as an early biomarker of cardiometabolic risk in young women with obesity.
- 1 September 2025
- Published by Periodic Publication Moldovan Journal of Health Sciences in Moldovan Journal of Health Sciences
- Vol. 12 (3) , 86-91
Osteocalcin and metabolic dysfunction in young women with obesity
Introduction. Osteocalcin, a bone-derived hormone, has emerged as a potential regulator of energy metabolism, with roles in insulin sensitivity, glucose homeostasis, and lipid metabolism. Although an inverse association between osteocalcin and body mass index has been previously reported, data on its link with metabolic parameters in young, otherwise healthy women with obesity remain limited. The objective of this study was to investigate the relationship between circulating osteocalcin levels and key metabolic parameters in this specific population. Material and methods. A cross-sectional observational study was conducted among 85 Caucasian women aged 18-45 years, without chronic disease or medication use. Participants were classified into two groups: normal weight (BMI 18.524.9 kg/m², n = 47) and with obesity (BMI ≥ 30 kg/m², n = 38). Anthropometric, hemodynamic, and biochemical parameters, including glucose, insulin, lipid profile, osteocalcin, and adiponectin, were assessed. Insulin resistance was evaluated using HOMA-IR and QUICKI. Group comparisons and Pearson correlation analyses were performed. Results. Osteocalcin levels were significantly lower in the group of women with obesity compared to the normal weight group (12.99 ± 4.7 vs. 19.75 ± 4.09 ng/mL, p less than 0.001). It was inversely correlated with BMI (r = - 0.56), waist-to-hip ratio, waist-to-height ratio, insulin, HOMA-IR, total and LDL cholesterol, and positively associated with QUICKI (r = 0.39) and adiponectin (r = 0.31) (all p less than 0.001). A progressive decline in osteocalcin levels was observed across obesity grades. Conclusions. Circulating osteocalcin is inversely associated with adiposity and metabolic dysfunction, suggesting its potential as an early biomarker of cardiometabolic risk in young women with obesity.
- Open Access
- 18 November 2024
- Published by AO Economie, Management si Psihologie in Medicina in Public Health, Economy and Management in Medicine
- No. 5(102),p. 13-17
Manifestările clinice, complicațiile și tratamentul acromegaliei
Acromegaly is a rare neuroendocrine disease that requires a specific approach in the evaluation of clinical symptoms. Evaluation of medical records of 28 patients with acromegaly admitted to the „Endocrinology” department, IMSP Republican Clinical Hospital „Timofei Moșneaga” during the period 2018-2023 were analyzed. In men the mean age of acromegaly onset is 25.5 (± 5,86) years, in women is 46.29 (± 11,85) years. The most common early manifestations: facial changes, enlargement of the extremities and headache. The most frequent symptoms detected during the disease: headache (64.29%), visual disturbances (60.71%), facies acromegalis (57.14%), leg enlargement (53.57%), arthralgias (50%). The most common complications in patients were the following: cardiomyopathy (67.86%), hypertension (57.14%), thyroid gland disorders (42.86%), type 2 diabetes (35.71%). Out of 24 patients - 15 patients (62.5%) had recurrence of acromegaly. Acromegaly affects almost all body systems: endocrine, nervous, cardiovascular, musculoskeletal and others, leading to a wide variety of clinical symptoms. The most common symptoms detected during the disease were associated with local tumor effects, hormonal disturbances and changes in metabolism.
- 18 November 2024
- Published by AO Economie, Management si Psihologie in Medicina in Public Health, Economy and Management in Medicine
- No. 5(102),p. 13-17
Open AccessManifestările clinice, complicațiile și tratamentul acromegaliei
Acromegaly is a rare neuroendocrine disease that requires a specific approach in the evaluation of clinical symptoms. Evaluation of medical records of 28 patients with acromegaly admitted to the „Endocrinology” department, IMSP Republican Clinical Hospital „Timofei Moșneaga” during the period 2018-2023 were analyzed. In men the mean age of acromegaly onset is 25.5 (± 5,86) years, in women is 46.29 (± 11,85) years. The most common early manifestations: facial changes, enlargement of the extremities and headache. The most frequent symptoms detected during the disease: headache (64.29%), visual disturbances (60.71%), facies acromegalis (57.14%), leg enlargement (53.57%), arthralgias (50%). The most common complications in patients were the following: cardiomyopathy (67.86%), hypertension (57.14%), thyroid gland disorders (42.86%), type 2 diabetes (35.71%). Out of 24 patients - 15 patients (62.5%) had recurrence of acromegaly. Acromegaly affects almost all body systems: endocrine, nervous, cardiovascular, musculoskeletal and others, leading to a wide variety of clinical symptoms. The most common symptoms detected during the disease were associated with local tumor effects, hormonal disturbances and changes in metabolism.
- Open Access
- 18 November 2024
- Published by AO Economie, Management si Psihologie in Medicina in Public Health, Economy and Management in Medicine
- No. 5(102),p. 46-50
Evaluarea riscului cardiometabolic la femeile de vârstă fertilă cu obezitate. date preliminare
Obesity is a chronic disease with extensive health consequences. Its prevalence is constantly increasing, including among children and young people. In this study we assessed the cardiometabolic risk and its correlation with leptin/adiponectin ratio in obese young women. We enrolled 72 apparently healthy women, comprising 36 with normal weight (BMI ≤ 25 kg/m²) and 36 with obesity (BMI ≥ 30 kg/m²). The mean age was 34.1±5.6 years. Clinical and paraclinical parameters were studied: body mass index (BMI), waist and hip circumference, waist-hip ratio, blood presure, serum level of glucose, insulin, leptin, adiponectin, total cholesterol, HDL cholesterol, LDL cholesterol. Compared to normal weight women, obese women have had significantly higher levels of leptin, insulin and blood glucose (p < 0.001). But the level of adiponectin was lower (p < 0.001). The leptin/adiponectin ratio had a positive correlation with BMI, waist circumferince, waist-hip ratio, blood glucose, insulinemia, HOMA-IR (Homeostatic Model Assessment for Insulin Resistance), LDL cholesterol and negative correlation with HDL cholesterol in the group of obese women. Research results revealed higher cardiometabolic risk in young women with obesity. The leptin/adiponectin ratio is in direct correlation with this risk, being a good predictor of insulin resistance.
- 18 November 2024
- Published by AO Economie, Management si Psihologie in Medicina in Public Health, Economy and Management in Medicine
- No. 5(102),p. 46-50
Open AccessEvaluarea riscului cardiometabolic la femeile de vârstă fertilă cu obezitate. date preliminare
Obesity is a chronic disease with extensive health consequences. Its prevalence is constantly increasing, including among children and young people. In this study we assessed the cardiometabolic risk and its correlation with leptin/adiponectin ratio in obese young women. We enrolled 72 apparently healthy women, comprising 36 with normal weight (BMI ≤ 25 kg/m²) and 36 with obesity (BMI ≥ 30 kg/m²). The mean age was 34.1±5.6 years. Clinical and paraclinical parameters were studied: body mass index (BMI), waist and hip circumference, waist-hip ratio, blood presure, serum level of glucose, insulin, leptin, adiponectin, total cholesterol, HDL cholesterol, LDL cholesterol. Compared to normal weight women, obese women have had significantly higher levels of leptin, insulin and blood glucose (p < 0.001). But the level of adiponectin was lower (p < 0.001). The leptin/adiponectin ratio had a positive correlation with BMI, waist circumferince, waist-hip ratio, blood glucose, insulinemia, HOMA-IR (Homeostatic Model Assessment for Insulin Resistance), LDL cholesterol and negative correlation with HDL cholesterol in the group of obese women. Research results revealed higher cardiometabolic risk in young women with obesity. The leptin/adiponectin ratio is in direct correlation with this risk, being a good predictor of insulin resistance.
- 1 April 2024
- Published by Periodic Publication Moldovan Journal of Health Sciences in Moldovan Journal of Health Sciences
- Vol. 11 (1) , 27-31
Epidemiology of type 2 diabetes and prediabetes in the adult population of the Republic of Moldova (preliminary data)
Introduction. Type 2 DM accounts for over 95% of all diabetes cases worldwide and represents an important and independent cardio-metabolic risk factor. This is the first national study (Epidemiological study of widespread endocrine pathologies (diabetes, obesity) in the Republic of Moldova and its management strategy) that analyzes the prevalence of type 2 diabetes mellitus (DM), prediabetes, obesity, and dyslipidemia in the adult population of Moldova. Material and methods. This is an epidemiological cross-sectional study with cluster random sampling. A face-to-face interview was conducted with the participants using a pre-tested semi-structured questionnaire. All biochemical tests were performed in a certified laboratory. Statistical analysis used Spearman’s correlation test, chi-square, and Wilcoxon tests. The Research Ethics Committee of Nicolae Testemițanu State University of Medicine and Pharmacy (Minutes 3 from December 28 2020) approved this study. Results. 728 individuals were enrolled, of which 2.5% had unknown DM. Advanced age, obesity, and dyslipidemia were influencing factors for diabetes. 21.4% of participants had prediabetes, with a higher prevalence in men than in women (28.3 % versus 18.9 %). Only 23.2% of men and 30.4% of women had a BMI within the normal range. Abdominal circumference (AC) values greater than 102 cm and 88 cm in men and women, respectively, were determined in 39.4% of men and 53.8% of women. Conclusions. Our study showed an increased prevalence of carbohydrate metabolism disorders, including prediabetes, as well as a high prevalence of abdominal obesity. Persons with unknown diabetes mellitus have been identified.
- 1 April 2024
- Published by Periodic Publication Moldovan Journal of Health Sciences in Moldovan Journal of Health Sciences
- Vol. 11 (1) , 27-31
Epidemiology of type 2 diabetes and prediabetes in the adult population of the Republic of Moldova (preliminary data)
Introduction. Type 2 DM accounts for over 95% of all diabetes cases worldwide and represents an important and independent cardio-metabolic risk factor. This is the first national study (Epidemiological study of widespread endocrine pathologies (diabetes, obesity) in the Republic of Moldova and its management strategy) that analyzes the prevalence of type 2 diabetes mellitus (DM), prediabetes, obesity, and dyslipidemia in the adult population of Moldova. Material and methods. This is an epidemiological cross-sectional study with cluster random sampling. A face-to-face interview was conducted with the participants using a pre-tested semi-structured questionnaire. All biochemical tests were performed in a certified laboratory. Statistical analysis used Spearman’s correlation test, chi-square, and Wilcoxon tests. The Research Ethics Committee of Nicolae Testemițanu State University of Medicine and Pharmacy (Minutes 3 from December 28 2020) approved this study. Results. 728 individuals were enrolled, of which 2.5% had unknown DM. Advanced age, obesity, and dyslipidemia were influencing factors for diabetes. 21.4% of participants had prediabetes, with a higher prevalence in men than in women (28.3 % versus 18.9 %). Only 23.2% of men and 30.4% of women had a BMI within the normal range. Abdominal circumference (AC) values greater than 102 cm and 88 cm in men and women, respectively, were determined in 39.4% of men and 53.8% of women. Conclusions. Our study showed an increased prevalence of carbohydrate metabolism disorders, including prediabetes, as well as a high prevalence of abdominal obesity. Persons with unknown diabetes mellitus have been identified.